Project Grant K23DK138292

Award Date 6/15/25
Completion Date 3/31/30
Dollars Obligated $185K
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Illinois, USA
Similar Awards
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) provides $667,726 to the University of Miami to conduct a clinical trial evaluating the impact of a culturally tailored anti-inflammatory diet on disease remission in Hispanic/Latino patients with mild to moderate ulcerative colitis (UC). The key objectives are to: 1) determine the effect of...
This federal Project Grant award, valued at $656,001.00, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award will support a research project titled "Plasticity of Type 3 Innate Lymphoid Cells Regulated by Intestinal Microenvironment" at the University of Illinois. The key objectives are to examine the environmental factors and mechanisms...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $151,643 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to The Regents of the University of Colorado, doing business as the University of Colorado-Denver. The grant, awarded on April 11, 2025, supports research to design and evaluate "proteolysis targeting chimeras" (PROTACs) that can stabilize hypoxia-inducible factors (HIFs) to enhance...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $551,112 to Children's Hospital Los Angeles (CHLA) to elucidate the role of deep crypt secretory (DCS) cells in colonic inflammation and tissue repair. The project aims to 1) determine if impaired DCS cell responses exacerbate colonic inflammation and limit tissue regeneration, 2)...
This $273,000 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) supports research conducted by Weill Medical College of Cornell University. The research aims to investigate how nociceptor sensory neurons and neuropeptides regulate intestinal inflammation and tissue protection in the context of inflammatory bowel diseases (IBD). The project seeks to...
This Project Grant award, totaling $233,600.00 and spanning September 1, 2024 to June 30, 2027, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports high-throughput functional analyses of genetic drivers of inflammatory bowel disease (IBD), a debilitating condition characterized by chronic inflammation and erosion of intestinal functions. The...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $497,370 Project Grant (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) to the Regents of the University of Michigan. The grant, titled "CD45 MEDIATED REGULATION OF PMN FUNCTION DURING INTESTINAL INFLAMMATION", will fund research to determine the effects of neutrophil-specific loss of the CD45 tyrosine phosphatase on intestinal inflammation and repair processes. The...
This federal Project Grant award, valued at $516,648.00 and granted by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), is focused on investigating the role of epigenetic memory in intestinal regeneration. The research aims to examine whether intestinal stem cells (ISCs) maintain a memory of inflammatory exposure, and how this affects their subsequent regenerative capacity....
This Project Grant award, worth $492,409, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award aims to evaluate the role of the creatine pathway in regulating intestinal goblet cell development and its impact on the microbiome and susceptibility to colitis. Specifically, the research will investigate the contribution of glycolysis on goblet cell...
This federal Project Grant award of $726,140.00 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant aims to elucidate the neural circuits and cellular mechanisms underlying visceral pain processing in the spinal cord and brainstem, with the goal of advancing understanding and treatment of visceral pain conditions such as irritable bowel syndrome,...

This $184,572 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) supports research to characterize the transmural nature of ulcerative colitis (UC) and its impact on disease outcomes. The University of Chicago is the prime recipient.

The research aims to: 1) Determine predictors of transmural structural alterations (TMA) to the bowel wall in UC patients; 2) Assess disease-related outcomes in UC patients with TMA and transmural healing; and 3) Examine the relationship between TMA of the rectal wall and rectal function. The research leverages a novel approach using intestinal ultrasound to evaluate the bowel wall, with the goal of identifying new therapeutic targets and endpoints for UC. The 5-year project period runs from June 2025 to March 2030.

Generated 7/1/25, 3:13 AM